These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36522349)

  • 1. Burkitt lymphoma.
    López C; Burkhardt B; Chan JKC; Leoncini L; Mbulaiteye SM; Ogwang MD; Orem J; Rochford R; Roschewski M; Siebert R
    Nat Rev Dis Primers; 2022 Dec; 8(1):78. PubMed ID: 36522349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
    Sang W; Tu D; Zhang M; Qin Y; Yin W; Song X; Sun C; Yan D; Wang X; Zeng L; Li Z; Xu K; Xu L
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23117. PubMed ID: 35757978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma.
    Xu L; Zhang M; Tu D; Lu Z; Lu T; Ma D; Zhou Y; Zhang S; Ma Y; Yan D; Wang X; Sang W
    J Pharmacol Exp Ther; 2023 Dec; 387(3):288-298. PubMed ID: 37875309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
    Molina E; García-Gutiérrez L; Junco V; Perez-Olivares M; de Yébenes VG; Blanco R; Quevedo L; Acosta JC; Marín AV; Ulgiati D; Merino R; Delgado MD; Varela I; Regueiro JR; Moreno de Alborán I; Ramiro AR; León J
    Oncogene; 2023 Nov; 42(45):3358-3370. PubMed ID: 37773203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt lymphoma- a rare but challenging lymphoma.
    Casulo C; Friedberg JW
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):279-284. PubMed ID: 30213397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.
    Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L
    Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
    Bornkamm GW
    Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
    Grande BM; Gerhard DS; Jiang A; Griner NB; Abramson JS; Alexander TB; Allen H; Ayers LW; Bethony JM; Bhatia K; Bowen J; Casper C; Choi JK; Culibrk L; Davidsen TM; Dyer MA; Gastier-Foster JM; Gesuwan P; Greiner TC; Gross TG; Hanf B; Harris NL; He Y; Irvin JD; Jaffe ES; Jones SJM; Kerchan P; Knoetze N; Leal FE; Lichtenberg TM; Ma Y; Martin JP; Martin MR; Mbulaiteye SM; Mullighan CG; Mungall AJ; Namirembe C; Novik K; Noy A; Ogwang MD; Omoding A; Orem J; Reynolds SJ; Rushton CK; Sandlund JT; Schmitz R; Taylor C; Wilson WH; Wright GW; Zhao EY; Marra MA; Morin RD; Staudt LM
    Blood; 2019 Mar; 133(12):1313-1324. PubMed ID: 30617194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.
    Vaillant V; Reiter A; Zimmermann M; Wagner HJ
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27752. PubMed ID: 30977593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
    Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells.
    Sall FB; Shmakova A; Karpukhina A; Tsfasman T; Lomov N; Canoy RJ; Boutboul D; Oksenhendler E; Toure AO; Lipinski M; Wiels J; Germini D; Vassetzky Y
    J Med Virol; 2023 Mar; 95(3):e28633. PubMed ID: 36866703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage of Epstein-Barr virus lytic infection leading to the "starry sky" pattern formation in endemic Burkitt lymphoma.
    Fujita S; Buziba N; Kumatori A; Senba M; Yamaguchi A; Toriyama K
    Arch Pathol Lab Med; 2004 May; 128(5):549-52. PubMed ID: 15086279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology: clues to the pathogenesis of Burkitt lymphoma.
    Magrath I
    Br J Haematol; 2012 Mar; 156(6):744-56. PubMed ID: 22260300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro.
    Chen S; Wang Z; Dai X; Pan J; Ge J; Han X; Wu Z; Zhou X; Zhao T
    Cancer Sci; 2013 Jul; 104(7):826-34. PubMed ID: 23521217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.
    Moormann AM; Bailey JA
    Curr Opin Virol; 2016 Oct; 20():78-84. PubMed ID: 27689909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.